Method of treating an epstein-barr viral infection
AssigneeKremers-Urban Company
InventorsSudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr., Ali A. S. Gawish
Life of this patent
Estimating the term…
Abstract
A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
Claims4
A method of treating an Epstein-Barr viral infection comprising administering to a mammal having Epstein-Barr virus infection a therapeutically effective amount of a mammalian liver extract, referred to as KU10,001, the extract being heat stable, insoluble in acetone and soluble in water.
Dependencies are inferred from the claim text.